Exploring Secondary Structure Predictions for RNA-Targeted Drug Discovery: Power and Challenges

探索RNA靶向药物发现中的二级结构预测:优势与挑战

阅读:1

Abstract

RNAs are increasingly recognized as promising drug targets, as both coding and noncoding RNAs act as key regulators in disease-related biological processes. However, a significant gap persists between the number of known RNA sequences and the solved RNA structures, posing a major bottleneck for RNA-targeted drug discovery. RNA secondary structure prediction offers the potential to facilitate the identification of druggable sites in novel RNA sequences by rapidly predicting base pairing patterns. In this study, we benchmarked widely used RNA secondary structure prediction tools against a newly curated dataset of ligand-bound RNA structures. We found that most tools achieve reasonable accuracy for RNAs with short sequences and simple motifs, but their performance declines for longer RNAs and those containing pseudoknots. Notably, prediction accuracy is reduced within ligand binding sites, where noncanonical base pairs and complex secondary structure elements are prevalent yet consistently unrecognized by the tools. Consequently, RNA ligand binding sites are poorly reconstructed by secondary structure predictions. This work provides the first comprehensive assessment of RNA secondary structure prediction for ligand-bound RNAs and demonstrates the challenges for integrating these methods into RNA-targeted drug discovery pipelines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。